Stephen Kanes - Jun 15, 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Chief Medical Officer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Stephen Kanes
Stock symbol
SAGE
Transactions as of
Jun 15, 2021
Transactions value $
-$58,859
Form type
4
Date filed
6/17/2021, 09:12 AM
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +3.5K +42.21% $0.00 11.8K Jun 15, 2021 Direct F1
transaction SAGE Common Stock Tax liability -$58.9K -1K -8.49% $58.80 10.8K Jun 15, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 8,750 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 3,500 shares.